Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function

Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells

(2011) Giridhar Kanuri et al.   LABORATORY INVESTIGATION

Role of the Inducible Nitric Oxide Synthase in the Onset of Fructose-Induced Steatosis in Mice

(2010) Astrid Spruss et al.   ANTIOXIDANTS & REDOX SIGNALING

Metalloproteinase mediated occludin cleavage in the cerebral microcapillary endothelium under pathological conditions

(2010) Mira Lischper et al.   BRAIN RESEARCH

Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study

(2010) G A Garinis et al.   INTERNATIONAL JOURNAL OF OBESITY

Matrix Metalloproteinase-9 Is Increased in Obese Subjects and Decreases in Response to Pioglitazone

(2010) Resat Unal et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice

(2010) Valentina Volynets et al.   JOURNAL OF LIPID RESEARCH

Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice

(2010) Giridhar Kanuri et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Endotoxin and Plasminogen Activator Inhibitor-1 Serum Levels Associated With Nonalcoholic Steatohepatitis in Children

(2010) Anna Alisi et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Effects of Metformin and Weight Loss on Serum Alanine Aminotransferase Activity in the Diabetes Prevention Program

(2010) Jonathan Krakoff et al.   Obesity

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease

(2009) Luca Miele et al.   HEPATOLOGY

Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice

(2009) Astrid Spruss et al.   HEPATOLOGY

Disruptions of occludin and claudin-5 in brain endothelial cells in vitro and in brains of mice with acute liver failure

(2009) Feng Chen et al.   HEPATOLOGY

Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease

(2009) Astrid Spruss et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Diabetes of the Liver: The Link Between Nonalcoholic Fatty Liver Disease and HFCS-55

(2009) Kate S. Collison et al.   Obesity

Effect of Obesity on Growth-related Oncogene Factor-α, Thrombopoietin, and Tissue Inhibitor Metalloproteinase-1 Serum Levels

(2009) Eléonore Maury et al.   Obesity

Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet-Induced Obesity and Diabetes in Mice

(2008) P. D. Cani et al.   DIABETES

Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes

(2008) Søren S Lund et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: Role of endotoxin

(2008) Ina Bergheim et al.   JOURNAL OF HEPATOLOGY

Fructose consumption as a risk factor for non-alcoholic fatty liver disease

(2008) Xiaosen Ouyang et al.   JOURNAL OF HEPATOLOGY

High Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Morbid Obesity: A Contributor to Severe Hepatic Steatosis

(2008) Jean-Marc Sabaté et al.   OBESITY SURGERY

Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents

(2008) Kristen J Nadeau et al.   PEDIATRIC DIABETES